Atwater Malick’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.05M | Buy |
27,778
+184
| +0.7% | +$42.9K | 1.54% | 15 |
|
|
2026
Q1 | $6.75M | Sell |
27,594
-4,017
| -13% | -$936K | 1.82% | 15 |
|
|
2025
Q4 | $6.54M | Sell |
31,611
-5,542
| -15% | -$1.1M | 1.8% | 15 |
|
|
2025
Q3 | $6.89M | Sell |
37,153
-11,843
| -24% | -$2.03M | 2% | 18 |
|
|
2025
Q2 | $7.48M | Buy |
48,996
+308
| +0.6% | +$47.3K | 2.37% | 18 |
|
|
2025
Q1 | $8.07M | Buy |
48,688
+973
| +2% | +$152K | 2.73% | 15 |
|
|
2024
Q4 | $6.9M | Sell |
47,715
-2,437
| -5% | -$378K | 2.31% | 19 |
|
|
2024
Q3 | $8.13M | Buy |
50,152
+312
| +0.6% | +$49.7K | 2.62% | 18 |
|
|
2024
Q2 | $7.28M | Sell |
49,840
-623
| -1% | -$92.7K | 2.51% | 18 |
|
|
2024
Q1 | $7.98M | Buy |
50,463
+610
| +1% | +$97.1K | 2.81% | 16 |
|
|
2023
Q4 | $7.81M | Buy |
49,853
+852
| +2% | +$131K | 3.06% | 15 |
|
|
2023
Q3 | $7.63M | Buy |
49,001
+1,770
| +4% | +$292K | 3.36% | 12 |
|
|
2023
Q2 | $7.82M | Buy |
47,231
+1,267
| +3% | +$204K | 3.34% | 13 |
|
|
2023
Q1 | $7.12M | Buy |
45,964
+1,233
| +3% | +$199K | 3.34% | 16 |
|
|
2022
Q4 | $7.9M | Buy |
44,731
+1,296
| +3% | +$224K | 3.89% | 10 |
|
|
2022
Q3 | $7.09M | Buy |
43,435
+1,104
| +3% | +$187K | 3.96% | 7 |
|
|
2022
Q2 | $7.51M | Buy |
42,331
+626
| +2% | +$112K | 3.95% | 9 |
|
|
2022
Q1 | $7.39M | Buy |
41,705
+1,487
| +4% | +$253K | 3.57% | 12 |
|
|
2021
Q4 | $6.88M | Buy |
40,218
+1,359
| +3% | +$222K | 3.19% | 16 |
|
|
2021
Q3 | $6.28M | Buy |
38,859
+1,337
| +4% | +$228K | 3.32% | 15 |
|
|
2021
Q2 | $6.18M | Buy |
37,522
+2,117
| +6% | +$350K | 3.42% | 14 |
|
|
2021
Q1 | $5.82M | Sell |
35,405
-2,047
| -5% | -$331K | 3.57% | 13 |
|
|
2020
Q4 | $5.89M | Buy |
37,452
+752
| +2% | +$111K | 3.7% | 12 |
|
|
2020
Q3 | $5.46M | Buy |
36,700
+875
| +2% | +$129K | 3.83% | 13 |
|
|
2020
Q2 | $5.04M | Buy |
35,825
+780
| +2% | +$114K | 3.97% | 9 |
|
|
2020
Q1 | $4.59M | Buy |
35,045
+1,815
| +5% | +$258K | 4.41% | 8 |
|
|
2019
Q4 | $4.85M | Buy |
33,230
+938
| +3% | +$127K | 3.85% | 12 |
|
|
2019
Q3 | $4.18M | Buy |
32,292
+831
| +3% | +$109K | 3.51% | 13 |
|
|
2019
Q2 | $4.38M | Buy |
31,461
+1,157
| +4% | +$160K | 4.02% | 13 |
|
|
2019
Q1 | $4.24M | Buy |
30,304
+649
| +2% | +$86.9K | 4.14% | 10 |
|
|
2018
Q4 | $3.83M | Buy |
+29,655
| New | +$4.14M | 4.28% | 11 |
|
Other funds holding JNJ
Atwater Malick's JNJ Position: Q2 2026 in Review
Atwater Malick increased its Johnson & Johnson (JNJ) stake by 0.67% in Q2 2026, buying an estimated $42.9K and bringing the position to 27,778 shares worth $7.05M. The position accounts for 1.54% of the portfolio, ranked #15.
Atwater Malick first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. The position peaked at $8.13M in Q3 2024. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Atwater Malick held 27,778 shares of Johnson & Johnson worth $7.05M as of Q2 2026.
- Atwater Malick bought 184 Johnson & Johnson shares in Q2 2026, an estimated $42.9K.
- Johnson & Johnson made up 1.54% of Atwater Malick's portfolio in Q2 2026, its #15 holding.
- Atwater Malick first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- Atwater Malick's Johnson & Johnson position peaked at $8.13M in Q3 2024.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Atwater Malick's 13F filing for Q2 2026, filed 27 Jul 2026.